RxDoctor Payments Data

Mary Bower, MD

Family Medicine · Fremont, OHNPI 1194798892

Payments from drug & device makers

$1,920in general payments, 2019–2025

Across 106 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$528
  • Novo Nordisk$306
  • Pfizer$140
  • AstraZeneca$128
  • GSK$122
  • Dexcom, Inc.$120
  • plus $575 from 16 others

What the payments were for

  • Food & beverage$1,920100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,920 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$115,685
Medicare patients
283
Services billed
1,717

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide56$87,008
EliquisApixaban89$77,157
JanuviaSitagliptin Phosphate68$63,868
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$51,822
JardianceEmpagliflozin47$48,564
TrulicityDulaglutide32$40,601
XareltoRivaroxaban40$36,745
FarxigaDapagliflozin Propanediol35$23,061
LinzessLinaclotide24$16,537
RybelsusSemaglutide11$9,799
Atorvastatin Calcium721$8,414
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog17$8,207
Advair HfaFluticasone Propion/Salmeterol15$7,723
VascepaIcosapent Ethyl21$7,185
Lantus SolostarInsulin Glargine,hum.Rec.Anlog48$6,737

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$306$96,80767 claims
PfizerEliquis, Paxlovid$140$82,824109 claims
MerckJanuvia$35$63,86868 claims
GSKTrelegy Ellipta$122$51,82244 claims
Boehringer IngelheimJardiance$36$48,56447 claims
Lilly USA, LLCTrulicity$65$40,60132 claims
AstraZenecaFarxiga$128$23,06135 claims
AbbVieLinzess$528$16,53724 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Fremont

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →